Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neoplasm Metastasis × Sunitinib × Clear all

Phase

Phase 2 19 Phase 1 3 Phase 3 2 Phase NA 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 6 Breast Neoplasms 4 Sarcoma 2 Melanoma 2 Urinary Bladder Neoplasms 1 Solitary Fibrous Tumors 1 Solid Tumors Refractory to Standard Therapy 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 Hemangioendothelioma 1 Gastrointestinal Stromal Tumors 1 Fatigue 1 Colorectal Neoplasms 1 Chondrosarcoma, Extraskeletal Myxoid 1 Chondrosarcoma 1 Breast Neoplasms, Male 1 Bone Neoplasms 1

Interventions

pembrolizumab 36 Nivolumab 20 Gemcitabine 18 Paclitaxel 17 Cyclophosphamide 17 Capecitabine 16 fludarabine 11 aldesleukin 11 Ipilimumab 11 130-nm albumin-bound paclitaxel 10 Docetaxel 9 Trastuzumab 8 Albumin-Bound Paclitaxel 8 Radiosurgery 7 Interleukin-2 7 Biopsy 7 Bevacizumab 7 fludarabine phosphate 6 Temozolomide 6 Specimen Handling 6 Irinotecan 6 Fluorouracil 6 Cisplatin 6 Cetuximab 6 Carboplatin 6 avelumab 5 Radiotherapy 5 Pemetrexed 5 Oxaliplatin 5 Magnetic Resonance Spectroscopy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00905021 2020-07-24

EXTENT

Baylor Breast Care Center

Phase 1/2 Terminated

4 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡